Reposition
Outcome Capital is a specialized life sciences and technology investment banking group. Its provide middle-market growth companies in the technology and life sciences markets with a value-added, client-centric approach to mergers & acquisitions, corporate finance and advisory services. The firm uses its proven ‘strategy-led execution’ approach to value enhancement by assisting boards and management teams in navigating both the financial and strategic markets and in implementing the best path for success. Outcome Capital’s strength stems from its unique ability to draw on its wide range of operational, strategic and investment experience, its expertise across the value chain, and its broad industry relationships.
Outcome Capital's Recent News & Articles
The volume of deals worldwide valued at more than $100 million plunged 37% to just 280 during the first...
Investment bankers’ advisory fees have plunged to the lowest level in almost a decade because of a prol...
SVB Financial Group, the former parent company of Silicon Valley Bank, has entered into an agreement to...
Mizuho Financial Group is forging further into U.S. investment banking through a deal to buy Greenhill ...
Federal Reserve Chair Jerome Powell finds himself in a difficult place that no central banker wants to ...
Swiss banking giant Credit Suisse on Wednesday saw its shares fall to a new record low, pressuring the ...
St. Louis-based investment bank Stifel Financial has agreed to acquire Torreya Partners, an M&A and pri...
Banks looking to boost their digital capabilities reportedly may be taking a closer look at acquisition...
JPMorgan Chase & Co. and Goldman Sachs Group Inc. were one and two in the rankings in investment bankin...
Recent figures compiled by M&A and corporate finance firm Hampleton Partners show a 46 percent increase...